Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Regulation of viral gene expression by the herpes simplex virus 1UL24 protein (HSV-1UL24 inhibits accumulation of viral transcripts).

Sanabria-Solano C, Gonzalez CE, Richerioux N, Bertrand L, Dridi S, Griffiths A, Langelier Y, Pearson A.

Virology. 2016 Aug;495:148-60. doi: 10.1016/j.virol.2016.05.006. Epub 2016 May 20.

2.

The ribonucleotide reductase R1 subunits of herpes simplex virus 1 and 2 protect cells against poly(I · C)-induced apoptosis.

Dufour F, Bertrand L, Pearson A, Grandvaux N, Langelier Y.

J Virol. 2011 Sep;85(17):8689-701. doi: 10.1128/JVI.00362-11. Epub 2011 Jun 22.

3.

The ribonucleotide reductase R1 subunits of herpes simplex virus types 1 and 2 protect cells against TNFα- and FasL-induced apoptosis by interacting with caspase-8.

Dufour F, Sasseville AM, Chabaud S, Massie B, Siegel RM, Langelier Y.

Apoptosis. 2011 Mar;16(3):256-71. doi: 10.1007/s10495-010-0560-2.

PMID:
21107701
4.

Two distinct chimeric potexviruses share antigenic cross-presentation properties of MHC class I epitopes.

Hanafi LA, Bolduc M, Gagné ME, Dufour F, Langelier Y, Boulassel MR, Routy JP, Leclerc D, Lapointe R.

Vaccine. 2010 Aug 2;28(34):5617-26. doi: 10.1016/j.vaccine.2010.06.024. Epub 2010 Jun 25.

PMID:
20600515
5.

The Epstein-Barr virus (EBV) deubiquitinating enzyme BPLF1 reduces EBV ribonucleotide reductase activity.

Whitehurst CB, Ning S, Bentz GL, Dufour F, Gershburg E, Shackelford J, Langelier Y, Pagano JS.

J Virol. 2009 May;83(9):4345-53. doi: 10.1128/JVI.02195-08. Epub 2009 Feb 25.

6.

New adenovirus vectors for protein production and gene transfer.

Massie B, Mosser DD, Koutroumanis M, Vitté-Mony I, Lamoureux L, Couture F, Paquet L, Guilbault C, Dionne J, Chahla D, Jolicoeur P, Langelier Y.

Cytotechnology. 1998 Nov;28(1-3):53-64. doi: 10.1023/A:1008013211222.

7.

PABPN1 polyalanine tract deletion and long expansions modify its aggregation pattern and expression.

Klein AF, Ebihara M, Alexander C, Dicaire MJ, Sasseville AM, Langelier Y, Rouleau GA, Brais B.

Exp Cell Res. 2008 May 1;314(8):1652-66. doi: 10.1016/j.yexcr.2008.02.005. Epub 2008 Feb 23.

PMID:
18367172
8.

Upregulation of cellular triacylglycerol - free fatty acid cycling by oleate is associated with long-term serum-free survival of human breast cancer cells.

Przybytkowski E, Joly E, Nolan CJ, Hardy S, Francoeur AM, Langelier Y, Prentki M.

Biochem Cell Biol. 2007 Jun;85(3):301-10.

PMID:
17612624
9.

The ribonucleotide reductase domain of the R1 subunit of herpes simplex virus type 2 ribonucleotide reductase is essential for R1 antiapoptotic function.

Chabaud S, Sasseville AM, Elahi SM, Caron A, Dufour F, Massie B, Langelier Y.

J Gen Virol. 2007 Feb;88(Pt 2):384-94.

PMID:
17251554
10.

The dynamism of PABPN1 nuclear inclusions during the cell cycle.

Marie-Josée Sasseville A, Caron AW, Bourget L, Klein AF, Dicaire MJ, Rouleau GA, Massie B, Langelier Y, Brais B.

Neurobiol Dis. 2006 Sep;23(3):621-9. Epub 2006 Jul 24.

PMID:
16860991
11.

Endothelial stress induces the release of vitamin D-binding protein, a novel growth factor.

Raymond MA, Désormeaux A, Labelle A, Soulez M, Soulez G, Langelier Y, Pshezhetsky AV, Hébert MJ.

Biochem Biophys Res Commun. 2005 Dec 23;338(3):1374-82. Epub 2005 Oct 26.

PMID:
16269129
12.

Novel fibrogenic pathways are activated in response to endothelial apoptosis: implications in the pathophysiology of systemic sclerosis.

Laplante P, Raymond MA, Gagnon G, Vigneault N, Sasseville AM, Langelier Y, Bernard M, Raymond Y, Hébert MJ.

J Immunol. 2005 May 1;174(9):5740-9.

13.

PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions.

Corbeil-Girard LP, Klein AF, Sasseville AM, Lavoie H, Dicaire MJ, Saint-Denis A, Pagé M, Duranceau A, Codère F, Bouchard JP, Karpati G, Rouleau GA, Massie B, Langelier Y, Brais B.

Neurobiol Dis. 2005 Apr;18(3):551-67.

PMID:
15755682
14.

Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40.

Hardy S, St-Onge GG, Joly E, Langelier Y, Prentki M.

J Biol Chem. 2005 Apr 8;280(14):13285-91. Epub 2005 Feb 4.

15.

Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells. A role for cardiolipin.

Hardy S, El-Assaad W, Przybytkowski E, Joly E, Prentki M, Langelier Y.

J Biol Chem. 2003 Aug 22;278(34):31861-70. Epub 2003 Jun 12.

16.

The R1 subunit of herpes simplex virus ribonucleotide reductase has chaperone-like activity similar to Hsp27.

Chabaud S, Lambert H, Sasseville AM, Lavoie H, Guilbault C, Massie B, Landry J, Langelier Y.

FEBS Lett. 2003 Jun 19;545(2-3):213-8.

18.

The R1 subunit of herpes simplex virus ribonucleotide reductase protects cells against apoptosis at, or upstream of, caspase-8 activation.

Langelier Y, Bergeron S, Chabaud S, Lippens J, Guilbault C, Sasseville AM, Denis S, Mosser DD, Massie B.

J Gen Virol. 2002 Nov;83(Pt 11):2779-89.

PMID:
12388814
19.
21.

In vitro interaction of the carboxy-terminal domain of lamin A with actin.

Sasseville AM, Langelier Y.

FEBS Lett. 1998 Apr 3;425(3):485-9.

22.

Inducible overexpression of a toxic protein by an adenovirus vector with a tetracycline-regulatable expression cassette.

Massie B, Couture F, Lamoureux L, Mosser DD, Guilbault C, Jolicoeur P, Bélanger F, Langelier Y.

J Virol. 1998 Mar;72(3):2289-96.

23.

The R1 subunit of herpes simplex virus ribonucleotide reductase is a good substrate for host cell protein kinases but is not itself a protein kinase.

Langelier Y, Champoux L, Hamel M, Guilbault C, Lamarche N, Gaudreau P, Massie B.

J Biol Chem. 1998 Jan 16;273(3):1435-43.

25.
26.

Improved adenovirus vector provides herpes simplex virus ribonucleotide reductase R1 and R2 subunits very efficiently.

Massie B, Dionne J, Lamarche N, Fleurent J, Langelier Y.

Biotechnology (N Y). 1995 Jun;13(6):602-8.

PMID:
9634800
27.

Affinity of synthetic peptides for the HSV-2 ribonucleotide reductase R1 subunit measured with an iodinated photoaffinity peptide.

Lamarche N, Gaudreau P, Massie B, Langelier Y.

Anal Biochem. 1994 Aug 1;220(2):315-20.

PMID:
7978273
28.

Escherichia coli and herpes-simplex-virus ribonucleotide reductase R2 subunit. Compared reactivities of the redox centres.

Atta M, Lamarche N, Battioni JP, Massie B, Langelier Y, Mansuy D, Fontecave M.

Biochem J. 1993 Mar 15;290 ( Pt 3):807-10.

29.

Structure-function studies of peptides inhibiting the ribonucleotide reductase activity of herpes simplex virus type I.

Gaudreau P, Brazeau P, Richer M, Cormier J, Langlois D, Langelier Y.

J Med Chem. 1992 Jan 24;35(2):346-50.

PMID:
1310120
30.

Coordination of copper(II) ions to catechoyl-dipeptides, the inhibitors of leucine aminopeptidase and ribonucleotide reductase.

Kozłowski H, Radomska B, Kiss T, Balla J, Nakonieczna L, Pastuszak JJ, Langelier Y.

J Inorg Biochem. 1991 Sep;43(4):779-87.

PMID:
1663992
31.

Affinity purification of active subunit 1 of herpes simplex virus type 1 ribonucleotide reductase exhibiting a protein kinase activity.

Paradis H, Gaudreau P, Massie B, Lamarche N, Guilbault C, Gravel S, Langelier Y.

J Biol Chem. 1991 May 25;266(15):9647-51.

32.
33.

High level expression in 293 cells of the herpes simplex virus type 2 ribonucleotide reductase subunit 2 using an adenovirus vector.

Lamarche N, Massie B, Richer M, Paradis H, Langelier Y.

J Gen Virol. 1990 Aug;71 ( Pt 8):1785-92.

PMID:
2167932
34.
35.
36.

Transformation of NIH 3T3 cells by herpes simplex type 2 BglII n fragment and sub-fragments is independent from induction of mutation at the HPRT locus.

Pilon L, Kessous-Elbaz A, Langelier Y, Royal A.

Biochem Biophys Res Commun. 1989 Mar 31;159(3):1249-55.

PMID:
2539146
38.

Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.

Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P.

J Biol Chem. 1987 Sep 15;262(26):12413-6.

39.

Identification of viral polypeptides involved in pseudorabies virus ribonucleotide reductase activity.

Cohen EA, Paradis H, Gaudreau P, Brazeau P, Langelier Y.

J Virol. 1987 Jun;61(6):2046-9.

40.
42.
43.

Specific inhibition of herpesvirus ribonucleotide reductase by a nonapeptide derived from the carboxy terminus of subunit 2.

Cohen EA, Gaudreau P, Brazeau P, Langelier Y.

Nature. 1986 May 22-28;321(6068):441-3.

PMID:
3012360
44.

5-Fluorouracil-metronidazole combination therapy in metastatic colorectal cancer. Clinical, pharmacokinetic and in vitro cytotoxicity studies.

Bardakji Z, Jolivet J, Langelier Y, Besner JG, Ayoub J.

Cancer Chemother Pharmacol. 1986;18(2):140-4.

PMID:
3791559
45.
46.

Increased mutation frequency after herpes simplex virus type 2 infection in non-permissive XC cells.

Pilon L, Royal A, Langelier Y.

J Gen Virol. 1985 Feb;66 ( Pt 2):259-65.

PMID:
2981968
47.

Bromodeoxyuridine resistance in CHO cells occurs in three discrete steps.

Bradley WE, Dinelle C, Charron J, Langelier Y.

Somatic Cell Genet. 1982 Mar;8(2):207-22.

PMID:
9732750
50.

Supplemental Content

Loading ...
Support Center